Wuhan Easy Diagnosis Biomedicine: Guojin Securities Co., Ltd. inspection opinions on the annual storage and use of funds raised by Wuhan Mingde Biotechnology Co., Ltd. in 2023

SZSI · Apr 26

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.